REGISTERED CHAIUTY NUMBER: 2911959 REPORT OF THE TRUSTEES AND UNAUDrrED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 FOR BRITISH GYNAECOLOGICAL CAIYCER SOCIETY
BRITISH GYNAECOLOGICAL CANCER SOCIETY CONfENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Pge Report of the Tru$tee5 I to 4 Independent ExxmiDer's Report Sttement of FInellI Activities Balsnee Sheet Notes Its the Financial Ststements 8 to 14
BRITISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 The tNstees present theii report with the financial statements of the Charity for the year ended 31 December 2024. The ttwt¢¢s hav¢ adopted ihe PToViSiOs of Accounting and Reporting by Chariti¢s- Stst¢m¢nt of R¢con]rndc Pral¢e applicable to chariti¢$ pr¢psJring their accounts in accordance with the Financial Rcporting Standard appli¢abl¢ ID the UK and Republic of Ireland (FRS 102) (effective l January 2019). OBJEcfIvES AND ACTIVITIES Objectives and 2im$ The objects ofthe charity are advanc¢ th¢ s¢i¢w¢ and art of gynaetological oncology for the befit of th¢ public. It achieves its obj¢ctives by: - Making grants to individuals - Sponsoring or undertaktng research in gynaecological oncology IGynOn¢l - Providing advocacy, advice and inforn]ation - Running consensus meetings for specific topi¢s in GynOn¢ - Publishing Clinical guidelines for diagttosls and management of g)ryw¢colo8ical callcers - Working with the Royal Coll¢g¢ of Obst¢tricians and Gynaecologists io develop training ¢ll1¢Ia -supporting professional devclopmcnt of mcrnbership - Acting as an umbrella or rcsourcc body - Supporting one national annual s¢i¢ntifi¢ me¢iing a y¢ar looking at aspects of gynaec4)logical oncology - Awarding prizes to the best oral and postcr pr¢s¢ntation at the ASM Publlc benefit The trnstees confirni that they have referred to th¢ guidance eontained in the Charity Commission's general 8uidanee on public benefit wh¢n r¢vi¢wiD8 the Charitys aims and objectivcs and in planning futur¢ activitics. ACHIEWTMENTS AND PERFORMANCE Charltable ActiYilie$ TILe BGCS continues to expand with increasing m¢rnb¢rship of all rnultidisciplinary professions involved itt ?a¢CO10g1cal cancer ¢ar¢. The key aims of the BGCS continue to be advocates in th¢ maDag¢tnmt of G)maecologic41 Cancer by education and pro]noting b¢st PTa¢tioe iu the care of women diagnosed with gJw¢cological ¢an¢¢r. In 2024, th¢ Annual Scientific Meeting took place on the Liveryool dockland5. Th¢ m¢¢ting was a great SUC¢¢5s with over 500 dcl¢gat¢s attcnding a two day tneetin¥. Delegates had lectures from natioThal and iDt¢rnational speakers. Delegate feedback on tbe meeting was excellent. During 2024, the BGCS held a dedicated oThe day meeting for unit lead clinicians, furth¢r str¢ngthening the role of the BGCS in supporting clinicians ill smaller cancer units. Iu Jalluary, the BGCS held th¢ annual trdinees meeting for sub speciality trainees. Training of our future gynaecological canc¢r hcalthcare professionals remains a priority, w¢ sUPPQrt the trainees with educational grants and the opportunity to attend the NatlODal PeTiioneal Carcinomatosis Centre in Basingstoke as a training fellow. During 2024, the BGCS agreed a strategic alliance witb the Intemational Gyna¢cological Caneer Soeiety (iGcs). Thc council have agreed to pay th¢ subs for 2 years. Thi5 strategic alliancc opens up new areas for educaiion. mentorship and training for our membcrs ad had been requested by our members it) a membership survey. In 2024, BGCS commissioned a national audit on the maDag¢m¢nt of EDdoTnetTial Caneer within the UK. This PToject. funded by BGCS and othcr funding partners will help to r¢vi¢w and shap¢ our manag¢ni¢nt of the wmmon¢st Gynaecological ¢an¢¢r. The BGCS to offu grants for research. During 2024, we fimded two posi doctoral researeh grant i Conjunction with W¢llbeing of Wornen and also smaller peer reviewed rearCh grants through the Bfjcs. In addition we offer Yarious prizes and tsavel grants to Tnembers of the society. The application numbets foT all grants continue to increase, rellectlng the popularity of our grants. Overall. Ihe BGCS is a thriving so¢iety and during 2024 achieved tis aims of advocating for th¢ diagnosis, manag¢m¢nt and care of women diagnosed with Ga¢cOlogical ¢an¢¢r. Page I
BRITISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 FINANCIAL REVIEW Flnallelal posltlDD The Charity incued a nci dcficit over income of £89.376 in the year (2023.. a net defitit of £3,846), thu¢ was a deficit of £102,736 on w)restricted fvnds and a net $UTplus of £13,360 on r¢strict¢d fund& As at 3111212024 thc uw$tri¢ted fimds sto(MJ at £546,223 (2023.. £635,999) alld [rithd funds stood at £13,360 (2023.. £nill and illls included baDk balanc¢s of £515.278 (2023.. £546,843). The trnstee5 consider the financial position of the clmrity to be satisfa¢tory. Rueryes poli¢y The Treasurer will monitor the fiDaneial reserves of th¢ ¢haTity and is responsible for recommending a resetv¢s poli¢y which will b¢ T¢vi¢w¢d by the Trustees on an annual basis. The ¢urrent r¢s¢ry¢s poli¢y was agreed ai th¢ council meettng in June 2017 and is based on the followiDg principals.. -The BGCS should keep res¢tves thai ¢an sustain the working of th¢ charity for a year. -The BGCS should uot keep Teserves th&t are excessive. Assun]ing the requirement for maintaining reserves for one year is met, th¢ charity should avoid keeping reserves water than 80D/o of tbe SUTn of th¢ annual income and expenditure averaged over five yeaTY -Wh¢n r¢rV¢S are exc¢ssive. the chlty should explore new avenues of charitable activity. Under the curmii reserves poliey res¢$ at ycar end continue to be high despite planned expendith on tunding the feasibility pilot of a National Endometrial Cancer Audit Pilot IECAP), fiwther expenditurc on the W¢binar educational programm¢ funding of 2 Colnsu$ meei]ngs aod fi]Ading of an additional sub-group. In 2020 Council agreed to addltional spending to support th¢ Train¢¢slTr4iners Annual SummiL discounted registrntiott fees to SllPPOrt Dse mcmb¢rs att¢nding Annual Scientific Meettng, i]Kreased expenditure on prizes. ttwards, travel fellowships and researchlaudit grant& STRUCTURE, GOVERNANCE AND MANAGEMENT Gt)vernlng dotument The charity is ntrOlled by ils governing docmnenL a deed of trw( aT]d constitut¢s an unincoTporated charity. The British G)maecological Cancer Society is conslltuted under a de¢d adoptd at th¢ time of th¢ inaugural meeting on the 6th October 1984 and arnended on th¢ 6th May 1988, 30th April 1994. 20th May 2004 and 21 Julle 2013. It is a registered charity, numb¢r 290959. Pag¢ 2
BRITISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 STRucfuRE, GOVERNANCE MANAGEMELYr Recruitment and appolntment of new trustees The otTJ¢e holder5 of the Society {Prcsident, Hon Seuetary and Hon Trcasurcr) have automatically held the role of Trustce since the inception of th¢ So¢i¢ty in 1984. It was de£ided that at ihe summer council meeiing of the society on 8th July 2015 that the society should fommlise the appointment of non-executiv¢ tru51¢¢s and this was ratifi¢d at th AGM of 10th July 2015. It was decided that the officeis of the council as de%ribcd in th¢ constitution of th¢ BGCS 2015 Settion {3) would be joined in the rol¢ of truste¢s by no less tban Iwo and no more thart four noTL-voting trustees to serv¢ for thr¢¢ y¢aTS. Th¢ aim of council was to seek applications from the most experieDc¢d Rndividuals within the membership and it was ¢nvisaged that such candidates would be either nearing the end of OT have retired from clinical practice. The memberskn"p was asked to self nominat¢ for the position or noTnillate a colleague if they were agreeable to takmg up the positio by Odober 31st 2015. Subsequenily Iwo individuals were identified who were approached and who both aept¢d th¢ position of trustee. Their appolnth)t was ratified at AGM of 15th May 2016. The newly appointcd trllstces were sent an invitation letter which dirxted thwi to background reading regarding tbeir statutory and society responsibilities. Both trust¢es a¢cepted by retum of post. The fiTSI r¢sponsibility dclcgatcd to the two n¢wly appointed Ite¢S was the M]ltm¢nt of a third non voting tnjstee. ideniified at the council meeting of 9th February 2017 and subsequently dircctly approached with the same invitalion letter us¢d preVioly. The third non-voting truee acccptcd thc position forntslly on 13th Marcb 2017 and this appointmenl was Tatified at the AGM on 15th Jun¢ 2017. this person has now st¢pp¢d from the trustee p051tiim for personal reasons at the end of 2020. A new tsustee with a non m¢dical background and expertisc in l¢gal affairs has SIte been appointed. The cunt Const]tIon12017) 5tat¢5 in r¢lation to trustees=_ S¢dioll 2 (Membership of the Society) Trnstees l. Trustees are required by the Charity Commissioll. 2. Trustees shall b¢ recornlnended by Council and ratified by the AGM. 3. Trnstees shall serve a minimurn le of thr¢¢ y¢ars and this term may be renewable for up io two fier tern. In ertAin circumstances the tern) may be exten(kd by a fiwth¢r olle year to allow for overlap and ensurtng suitable ndidat¢s are in post to provide continuity to the Society. 4. Therc shall be a mininwm of 2 and a n]aximum of 4 trustees who will not have voting rights. 5. TtteS shall be individuals whose qualifications and motivation would be of value ro the BGCS in promoting its goals within the rules of its ch8fEtable status. Risk maD#geme*t The trnstees have a th]ty to identify and review the risks to which the Charity is exposed al ty ¢n$ur¢ appropriate Controls are it) pla¢¢ to provide re&wnable assurance against fraud and error. REFERENCE AND ADMINISTRATIVE DETAILS Registered Cbarlty number 290959 Prlndpal address Glaslyn Ffordd Y Parc Parc Menai Batsgor Gwynedd LL57 4FE Trustees Mrc Chan Professor J Shepherd MsBRai Mr S Dobbs- (Presidclltl Mr A J Phillips- ITr¢25urer) K B Gajjar- (Secretary) Pag¢ 3
BIUTISH GYNAECOLOGICAL CANCER SOCIETY REPORT OF THE TRUSTEES FOR THE YEAR ETrIDED 31 DECEMBER 2024 REFERENCE AND ADMINISTRATJVE DETAILS Independent Examlner Colin Bell FCCA William8 D¢nton Cyr Chanered Certified A¢¢outttatsts fjlaslyn Ffordd y Parc Parc Menai Bangor GW1Cdd LL57 4FE TRUSTEES, RESPONSIBILITY STATEMEP4T trustees are r¢sp¢)nsibl¢ for pr¢paring the Report of the TnteeS and the financial statements ith a¢¢ordall¢e with applicable ]aw and United Kingdom A¢¢ountillg Standards {United Kingdom fjara]ty Ac¢¢pted AuountiDg Practic¢). Charity law requitrs th¢ trust¢¢s to pr¢par¢ fiDancial 51at£m¢nts for ¢ach financial year. Uth that law. tbe trSte¢S hav¢ ¢IKted to PT¢Paf¢ the financial ststements in accordance with Uniied Kingdom Generally A¢¢¢pt¢d Accounting Praciice (Uniied Kingdom Accouniing Standards al appli¢abl¢ law). Under ¢haTity law th¢ INstees must not appTove the fjnancial statements unless they are satisfied that th¢y give a true and fair view of the stale of affairs of the eharity and of the incoming rCWuw and application of resources, ittcluding the income and expenditur¢, of th¢ charity for that period. In PTeparing those finla1 statements, the trnstees are required select witable accounting po]icies and th¢n opply thcm consistently, observe th¢ mcthods and PTinciples in the Charities SORP. n)ake judgcments and estimates that ar¢ r¢asonabl¢ and prudetst" prepare the finan¢tal statements on the going concern basis unless it is inappropriatc to presume that the chaTity wil] continue in bwiness. The trnstees are rcsponsiblc for kceping prop¢r a¢¢ounting records vAJich disclose reasonable accuracy at any time th¢ financial position of tbe charity alld io ellable them to ensure that the financial statements comply with the Charities Act 2011 and The Charity (Aecounts and Reports) Regulations 2008. Thoy ar¢ also responsible for safeguarding the assets of the eharity and hence for taking &9)nabl¢ st¢p$ for tbe prevention and detection of fraud ktLd other trregulariti¢s. Approved by order of the board of trustees on 27 August 2025 and signed on its behalf by.. MT S Dobbs - Trustec Pa8e 4
INDEPENDENT EXAI¥IINER'S REPORT TO THE TRIJSTEES OF BRITISH GYNAECOLOGICAL CANCER SOCIETY Indtpendent ex&miner'$ report to the trustees of British GynaecologbI Cne¢r $IetY I repon io the ch8rity trustecs on ]ny tx1natIon of th¢ ac¢ounts of British Gynaecologi¢a] Cancer So¢iety (the Trnstl for the year ended 31 1knb¢r 2024. ReJponsibllities and basi5 of report A$ thr chaTity trustees of the TN51 you are responsible for the pr¢paration of the accounts in #Crdance with the requirements of the Charities A¢t 2011 I'the Act,). J report in respect of my examinalion ofthe Trusfs accounts carried out under Section 145 of th¢ Act and in ¢drying out my examinatÉon I have followed all appli¢able Dire¢tions given by the Charity Commission under Se¢iion 145(5)0>) of the Ad. Jnd¢p¢Md¢DI ¢xgminer's stlernent Since your charity5 gross iEJcome exceeded £250.000 your examiner must be a member of a listed body. I can confirm that l am qualified to undcrtake the examirtation beV$¢ l am a member of the Associaliom of Chartered c.ertified A¢nIan. whi¢h is on¢ of the listed bodie I have completsd my examination. l L¥)nfirm that tho ttthterial matters hav¢ corne to my xttention in connection with the examination giving me cause to believe that in any material spe.. a¢o)untill8 r¢cords were not k¢pt in iespect of the Trnst as required by Section 130 of th¢ ArL' or the aCCQUEJt5 do not accord with tknse records. or th¢ aOUnts do not cotnply 74.ith the applicable r¢quir¢ments eoncerning the fornh and cont¢M of a¢cowits s¢1 out in the Charities (Accounts and Reports) Regulations 2008 oth¢r than any requirement that the accounts give a tnK ond fair Triew which is not amatter ¢onsidered as part of an independent ¢xaTninaliort. I have no concerns and have ¢OTne acmss no other matters in eontke¢tion with th¢ examin*ion lo which attention sIUld be drawn in this r¢port in order to enable a proper understanding of th¢ accounts to be reached. Colin Bell FCCA Williams Denton Cyf Charter¢d C¢rtificd Accountants Gl&slyn Ffordd y Parc Parc M¢nai Ban8or GMyn¢dd IL57 4FE Page 5
BRITISH GYNAECOLOGICAL CANCER SOCIETY srATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2024 2024 Total funds 2023 Total fi]nds Unre5trictrd fund Restrict¢d funds Notes COME AND ENDOWMENTS FROM Charitabl¢ activities To advance the science aDd art of 8ynaewlogiul oncology for the benefit of the publA¢ 3411ffi15 62JOO 403,IJS 322,952 InvestmeDt income 9,738 9,738 6.624 350J53 62,500 412,853 329,576 EXPENDITURE ON Charit4ble *etivities To advance the science alld art of gYna10gl¢al Oncolo for the benefit of the public 453,089 49,14 502329 333.422 NET INCOMEI(EXPENDfnJRE) (102.736) 13J60 {89J70) (3,846) RECONCILIATION OF FUNDS Totsl funds brough¢ foti¥ard 635599 635599 639,445 TOTAL FUNDS CARRIED FORWARD 532063 13J60 546J23 635.599 CONTINUING OPERATIOIYS All in¢ome &Dd expertditure has arisen from continuing activities. The notes forni part of these financial $tatern¢nts Page 6
BRITISH GYNAECOLOGICAL CANCER SOCIETY BALANCE SHEET 31 DECEMBER 21124 2024 Total fund$ 2023 Total fimds Unrestrict Restricted fimds Notes CURRENT ASSETS Dcbtors Cash at bank 123,959 501,918 123.959 515378 94,595 546.843 13J60 625,877 13J611 639237 641.438 CREDITORS Amounts falling due within one year 10 (93,014) {93.014) (5,839) NET CURRENT ASSETS 532,863 13J60 546223 635,599 TOTAL ASSETS LESS CURRENT LIABILrrtES 532,863 13J60 546223 635,599 NET ASSETS 532,863 13J60 $46,223 635.599 FUNDS Unrcstricted fi]nds Restrieied fimds 532,863 13J60 635,599 TOTAL FUNDS 546,223 635.599 The financial stat¢Jn¢nts w¢r¢ approved by the Board of Tnte¢S 2thd authorised for issue on 27 August 2025 and wcre Signed on its bebalf by-. Mr S Dobbs- Tnte¢ The notes forn) part of these financial statements Page 7
BIUTISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FL¥ANCIAL STATEMENTS FOR THE YEAR Ef4DED 31 DECEMBER 2024 AccoiJiYfiNG POLICIFS Basls of prepxrlng th¢ fln#n¢l#l $t4frmexts The financial statements of the charity, wthich is a public benefii entity under FRS 102. havc been Pr¢pad in accordance with Ihe Charities SORP (FRS 102) 'Accounting and R¢porting by Charities.. Statement of Recommeed Praotic¢ appli¢able to charities pr¢p2ring thcir accounts in accordallce with the FitiaELcitiI Rcporting Standard applicable in the UK and Republic of trelalld (FRS 102) (effective l January 2019),, Financial Reporting Standard 102 Tbe Financial Reporting Standard appli¢ablc in the UK and Republic of Ireland, and the Charities Act 2011. Thc financial statcments have been prepared Uter the historical cost ¢onv¢ntion. ID¢ODie Income is recognised when the charity has ¢ntitl¢rn¢nt to the thnds, any perfornunce conditions attached to the I1)¢ hav¢ been met, it is probable that the it)¢ome will be received and the amount canbe measllred r¢liably. kncome from Government atrj other llts, wheth¢r '¢apital' grdnt5 or 'Tevenu¢' gTants, is OgniSed the charity has entitlerna lo tbe funds, any perforn]an¢e conditions attached to the grants have be¢n llt, it is probable that the income will be received and tb¢ amount can be measured reliably and is not d¢ferr¢d. ExpeDdl¢ure Irrecowerable vat Liabilities are recognised as expenditure as soon as is a Icgal or ¢oJJstrwlive obligation committing tbe ¢haTity to that pditure. it is probable that a transfer of economic benefits will be required in settlem¢nt and the amowil of the obligation can be measured reliably. Expenditure is accounted for on an b&sis and has been classified under headingg that a8gate all cost r¢lat¢d to the ¢at¢gory. Where Costs cannot be directly
ttributed to particular h¢adings they have been allocated kn activities on a basis Colstent with the of
TesouTces. Irrttoverable VAT ig charged ag a cost iti the $tatcm¢nt of financial activitics. T*xatloll Tbe charity is exetnpt from corporation tsx on its charitable activities and is registered fot VAT purpo3u. Unrestricted ttds can be used in accordance with the charitable objectives at the discretion of th¢ twste¢s. Restricted funds can only b¢ us¢d for parti12T restricted pu4ioses within the objects of the charity. Resttictions aTÉS¢ spec2fied by the donor or when fimds are rnised for particular restricted PUTPOSes. Further explanation of the natur¢ and purpose of each fid is included in the notes to the financial stafrm¢Tht$. INVESTMEiYf INCOME 2024 2023 Dcposii account Illtert 9,738 6.624 Page 8 continued...
BRITISH GYNAECOLOGICAL CANCER SOCIETY Tr40TES TO THE FINANCL4L STATEMENTS- eODtlnued FOR THE YEAR EIWED 31 DECEMBER 2024 INcOL1 FROM CHARITABLE ACTIVITIES 2024 2023 Activity To advance th¢ sci¢llc¢ and art of gynaecological oncology foT th¢ ben¢fil of the public To advance the l¢ll¢¢ and art of gYt¢¢01Ogl¢al oncology for the benefii of the public To advanc¢ thc s¢1¢tC and art of gynaeco1ogil oncology for the benefit of the public To advan¢¢ th¢ sGiencc and art of gynaecological onlogY for th¢ b¢n¢fit of the publi¢ To advance the science and art of g)&e¢01ogJcJl OnlOgY for the b¢nefit of the public To advance ihe sci¢n¢¢ alld art of gynaecological oncology for the benefit of the public To advance the science hnd art of gYa¢10SICal oncology for the benefft of the public To advance the sci¢nc¢ and art of gynaeeological oncology for tbe benefit of the public To adYanc¢ the scienee and art of gynaecological oncology for the benefit of the public Grants 62,51 16,800 Sponsorships 833 4,583 Delegate f¢¢$ 17JSII 14.185 Sthscriptions 56,038 60,045 Subvention 6,000 ASM Social Programn)e 8,230 7,992 ASM Delegate incom¢ 137,110 87,310 ASM Sponsorsh4) incott]e 120,863 118,700 Sundry income 150 7,337 403,115 322,952 Grants Teceived. included in the above, kre as follows". 2024 2023 R K Wright Ovarian Cancer Action Merck Sharp & DohTne (Endometrical Cancer Audit) GlaKoSmithKlinc (Et)dometrial Cancer Audit) Eisai Lid (Endornetrial Cancer Audit) British Assoc. of G)maecological Pathologists (Endon*tri31 C2n¢er Audit) 1,000 15,8(Ml 30,1)00 20,000 5,1)00 7,SOO 62,$110 16,8 P8ge9 ¢ontinued...
BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENTS- contlnued FOR THE YEAR ENDED 31 DECEMBER 2024 CHARITABLE AIVITIEs COSTS Support costs (see not¢ 5) Direct Costs Totals To advance the scienee and art of gjmaecological oncology for the benefit of the pllblie 458,776 43,453 5112229 SUPPORT COSTS Governance costs Managemenl Totals To advance the s¢i¢n¢¢ aDd art ol 8yna¢¢ological oncology for the benefit of the public 32,914 10,539 43,453 INDEPEI¥DENT EXAMINER'S FEES 2024 2023 Ind¢p¢nd¢nt ¢xamin¢Es fees 2,500 3.600 TRUSTEES, REMUNERATION AND BENEFrrs Thcr¢ w¢re no trustees, remulleratioll or other benefits ftpr the year ¢nd¢d 31 Dece>¢[ 2024 nor for the year ended 31 DeceJnb¢r 2023. Trustees, expenses 2Q24 2023 Tnt¢¢$' expenses 5979 4,618 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES Unr$tri¢l¢d fimd nds fjmds INCOME AND ENDOWMENTS FROM Charit8We 4ftivities To adyance the science and art of gythaecological oncology for the brn¢fit of the publi 322.952 322,952 Investmetst itieome 6,624 6,624 Total 329,576 329,576 EXPENDITURE ON Page 10 continued...
BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMLYTS- ¢ontlDued FOR THE YEAR ENDED 31 DECEMBER 2024 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES- continued Unrestricted Restricted fimd fijnds Total funds Charltable actlvltles To advanc¢ th¢ s¢i¢nce and art of g>Traecological ODcology for th¢ b¢n¢fit of the pDbli¢ 333,422 333.422 NET INCOMEI(EXPENDITURE) (3,846) (3.8461 RECONCILIATION OF FUNDS Total ndS brogknt forward 639.445 639,445 TOTAL FUNDS CARRIED FORWARD 635,599 635.599 DEBTORS: AMOUNTS FALLINC DUE IVITlllN ONE YEAR 2024 2023 Other debtors VAT PrepaJryr¢nts 67J13 5066 51,080 88,186 4,316 2,093 123,959 94,595 10. CREDITORS: AMOUNTS FALLING DUE WTTHIN ONE YEAR 2024 2023 Other creditors Deferred income Accrued cxpeJ]ses 46,759 43,755 2,5110 2,239 3,600 93,014 5,839 ii. MOVEMENT IN FUNDS Net nx)v¢m¢ut in knds At 31.12 24 At 1.1.24 Unre$tri£ted fvnds General fund 635,599 (1•2,736) 532003 Restrlcted (und$ Endom¢trial Cancer Audit X3J60 13J60 TOTAL FUI¥DS 635,S99 (89,376) Pa8ell continucd...
BRJTISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCLiL sfATEMENTS- continued FOR THE YEAR ENDED 31 DECEMBER 2024 M0VELlNT JN FUNDS- contlnued Net rn0¢t in fiumls. included in the above are a5 follows.. RourCeS exp¢ryd¢d Movement resoutfe5 Unrestricted fuDd8 Gffleral fund 350,353 (453,089) (1112.730 Restrlcted funds Emdon*trial Cancer Audit 62,500 {49,140) 13J60 TOTAL FUNDS 412,853 1502229) 189J76) Cowpar8tiYes for DKbvement ID fuDdg Net movement in fijnds At 1.1.23 31.12.23 Unrestrlrted fuAd8 Gcncral fund 639.445 (3,846) 635.599 TOTAL FUI¥DS 639,445 (3,840 635.599 Comparativc net movement in nds, included in the alxive are as follows.. Incoming Resources ¢xp¢T Movement in fimds UDrestricted fvDds General fi]ttd 329.576 (333,422) {3,846) TOTAL FUNDS 329,576 (333.422) (3,846) Pagc 12 ontinued...
BRITISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCIAL STATEMENTS- eontlnued FOR TIIE YEAR ENDED 31 DECEMBER 2024 ii. MOVEMENT IN FUNDS- contlnued A CUTr¢nl ye8r 12 months and prior year 12 months ¢ombin¢d position is ag follows.. N¢t movement in fimds Ai 31.12.24 At 1.1.23 Unreytri¢ted fund$ Gcneral fund 639,445 (106,582} 532,863 Restrlcted funds Endometrial Cancer Audit 13,360 13.360 TOTAL FUNDS 639,445 {93,2221 546,223 A cu¢nt yur 12 nhinths and prior year 12 months combined net Jnovement in fimds, included in th¢ aboY¢ a as follows.. lll¢omin8 resou¢& Resources expended Movemenl in fimds UnrestTltted hnds General fund 679,929 (786,5111 1106,582) Restricted funds Endometrial Caneer Audit 62,500 (49,1401 13,360 TOTAL FUNDS 742,429 (835,6511 (93.222) Purpose of the Restrkted FuDds Endometrigl Can¢¢r AudRt The BGCS have commission¢d a two year rctrosprGtiYe audit into the incidence, mortality and treatmeni of Endometrial ll¢er in the UK. The E]Klometrial Cancer Audii Project (ECAPI has b¢en co-funded by BGCS and other chaTlti¢s as w¢ll as T¢CelYLng grants from some pharnCeUI1Ca2 ¢ompani¢s.Thc projcct will aid th¢ Gynaerological ¢anc¢r community ill plannin8 appropria¢e tr¢atm¢nt and also assess if there are regional vaTiations iti the management of endom¢trial cancer within the UK Page 13 continued...
BIUTISH GYNAECOLOGICAL CANCER SOCIETY NOTES TO THE FINANCLIL STATEMENTS- CODtinued FOR THE YEAR ENDED 31 DECEMBER 2024 12. RELA TED PARTY DISCLOSURES Due to the naknre of the clwitY$ operationi and ¢omposition of th¢ board of trte¢S and m¢mbership both trust¢¢$ and nymbcrs will pay subscriptions and fees to the Charity, other than these no matcrial tramactions have been tdentified which should be disclosed. Page 14